🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

4 recruiting trials

for Postprandial Distress Syndrome

A Study of Lianxiaxiaopi Granules in the Treatment of Postprandial Distress Syndrome NCT06696261Phase 318 sites📍 Beijing📍 Lanzhou📍 Guiyang Tasly Pharmaceutical Group Co., Ltd · Tests: Lianxiaxiaopi Granules, a simulated agent of Lianxiaxiaopi Granules Primary Care dySpEpsia rikkuNshiTo NCT06482671Phase 31 site📍 Leuven Universitaire Ziekenhuizen KU Leuven · Tests: Rikkunshi-to, Placebo Budesonide as a Treatment for Functional Dyspepsia NCT06841406Phase 41 site📍 Leuven Universitaire Ziekenhuizen KU Leuven · Tests: budesonide, Mannitol Exposure-Based CBT for Avoidant/Restrictive Food Intake in Functional Dyspepsia NCT05587127NA1 site📍 Boston Massachusetts General Hospital · Tests: Cognitive Behavioral Therapy
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy